Patents by Inventor Clarient Diagnostic Services, Inc.

Clarient Diagnostic Services, Inc. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • REAGENTS AND METHODS FOR USE IN CANCER DIAGNOSIS, CLASSIFICATION AND THERAPY
    Publication number: 20130210677
    Abstract: Methods and reagents for classifying tumors and for identifying new tumor classes and subclasses. Methods for correlating tumor class or subclass with therapeutic regimen or outcome, for identifying appropriate (new or known) therapies for particular classes or subclasses, and for predicting outcomes based on class or subclass. New therapeutic agents and methods for the treatment of cancer.
    Type: Application
    Filed: April 15, 2013
    Publication date: August 15, 2013
    Applicant: Clarient Diagnostic Services, Inc.
    Inventor: Clarient Diagnostic Services, Inc.
  • TLE3 AS A MARKER FOR CHEMOTHERAPY
    Publication number: 20130079392
    Abstract: Methods of using TLE3 as a marker for predicting the likelihood that a patient's cancer will respond to chemotherapy. Methods of using TLE3 as a marker for selecting a chemotherapy for a cancer.
    Type: Application
    Filed: November 27, 2012
    Publication date: March 28, 2013
    Applicant: CLARIENT DIAGNOSTIC SERVICES, INC.
    Inventor: Clarient Diagnostic Services, Inc.